The “eTYP” is a medical device that combines an affordable smart pill box and a supporting reminder system. Its purpose is to monitor and track Tuberculosis (TB) patients medication adherence by using a digital telemonitoring ecosystem.
Worldwide, 10 million people are estimated to have TB, of which 25% are in India. Treating TB is challenging – it is a long and arduous treatment process taking pills every second day for at least six months.
There are a range of access, social stigma and personal pressures on TB patients meaning the patient may not complete their treatment. In urban centers only 30% of patients complete their treatment. If not completed, patients develop Drug Resistant TB, which is ~10 times more expensive and more difficult to treat.
The eTYP has two parts – a connected plastic pillbox and unique pill blister pack. The pillbox enclosure protects the pills inside their pack and contains a processor, screen and battery. The blister pack has a pattern of conductive lines leading from each pill cell to the device.
Each week, patients get their medication and insert a pack is into the device. Each pill extraction is registered by breaking an electric trace that is embedded into the blister packs foil. The eTYP electronic module records the pills extraction as a unique code and can be the transmitted via 3G cellular network.
Should the patient fail to take the required pills, the unbroken circuit will notify the eTYP system and a sms or phone call will be generated as a reminder continually until an action is taken. The same results can be achieved In rural areas without 3G, applying a unique reminder and tracking system on any cellular phone.
This solution integrates seamlessly with existing government TB treatment programs and is designed to digitise and automate the internationally accepted WHO treatment plan.
This product was developed in the Israel-India Med4Dev Hackathon, supported by MATIMOP, and the Pears Program for Global Innovation, where over a thousand participants worked on health challenges simultaneously in Israel and India. It won the eHealth Israel Prize.